USD 27.02
(-1.92%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 9.11 Million USD | 1703.54% |
2022 | 505.29 Thousand USD | 127.45% |
2021 | 222.15 Thousand USD | -37.56% |
2020 | 355.79 Thousand USD | -82.04% |
2019 | 1.98 Million USD | 32.09% |
2018 | 1.5 Million USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 1.2 Million USD | -0.33% |
2015 | 1.2 Million USD | 13846.17% |
2014 | 8633.00 USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 189.25 Thousand USD | -76.63% |
2011 | 809.69 Thousand USD | 85.99% |
2010 | 435.34 Thousand USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 3069.00 USD | -50.82% |
2004 | 6240.00 USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | -100.0% |
1999 | 3050.00 USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 8.76 Million USD | -3.79% |
2024 Q2 | 14.37 Million USD | 63.91% |
2023 Q2 | 1.77 Million USD | -4.29% |
2023 FY | 9.11 Million USD | 1703.54% |
2023 Q4 | 9.11 Million USD | -19.39% |
2023 Q3 | 11.3 Million USD | 535.3% |
2023 Q1 | 1.85 Million USD | 267.94% |
2022 FY | 505.29 Thousand USD | 127.45% |
2022 Q1 | 187.04 Thousand USD | -15.81% |
2022 Q2 | 151.37 Thousand USD | -19.07% |
2022 Q3 | 567.74 Thousand USD | 275.05% |
2022 Q4 | 505.29 Thousand USD | -11.0% |
2021 FY | 222.15 Thousand USD | -37.56% |
2021 Q1 | 323.52 Thousand USD | -9.07% |
2021 Q2 | 290.75 Thousand USD | -10.13% |
2021 Q4 | 222.15 Thousand USD | -13.46% |
2021 Q3 | 256.71 Thousand USD | -11.71% |
2020 FY | 355.79 Thousand USD | -82.04% |
2020 Q1 | 450.46 Thousand USD | -77.27% |
2020 Q2 | 811.62 Thousand USD | 80.18% |
2020 Q3 | 855.59 Thousand USD | 5.42% |
2020 Q4 | 355.79 Thousand USD | -58.42% |
2019 Q4 | 1.98 Million USD | -1.51% |
2019 Q1 | 1.63 Million USD | 8.79% |
2019 Q3 | 2.01 Million USD | 25.22% |
2019 Q2 | 1.6 Million USD | -1.55% |
2019 FY | 1.98 Million USD | 32.09% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | 1.5 Million USD | 0.0% |
2018 Q4 | 1.5 Million USD | 0.0% |
2018 FY | 1.5 Million USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q2 | 1.2 Million USD | 0.0% |
2017 Q3 | - USD | -100.0% |
2017 FY | - USD | -100.0% |
2017 Q1 | 1.2 Million USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q1 | 1.2 Million USD | -0.1% |
2016 FY | 1.2 Million USD | -0.33% |
2016 Q2 | 1.2 Million USD | -0.1% |
2016 Q4 | 1.2 Million USD | -0.03% |
2016 Q3 | 1.2 Million USD | -0.1% |
2015 Q4 | 1.2 Million USD | 0.33% |
2015 Q2 | 1.2 Million USD | 15982.95% |
2015 Q1 | 7508.00 USD | -13.03% |
2015 FY | 1.2 Million USD | 13846.17% |
2015 Q3 | 1.2 Million USD | -0.62% |
2014 FY | 8633.00 USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | 8633.00 USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2013 Q3 | 103.05 Thousand USD | -27.76% |
2013 Q4 | - USD | -100.0% |
2013 Q1 | 174.46 Thousand USD | -7.81% |
2013 Q2 | 142.65 Thousand USD | -18.24% |
2012 FY | 189.25 Thousand USD | -76.63% |
2012 Q2 | 447.45 Thousand USD | -55.66% |
2012 Q3 | 287.56 Thousand USD | -35.73% |
2012 Q4 | 189.25 Thousand USD | -34.19% |
2012 Q1 | 1 Million USD | 24.63% |
2011 Q3 | 509.64 Thousand USD | 5.16% |
2011 Q4 | 809.69 Thousand USD | 58.87% |
2011 FY | 809.69 Thousand USD | 85.99% |
2011 Q2 | 484.64 Thousand USD | 5.38% |
2011 Q1 | 459.91 Thousand USD | 5.64% |
2010 FY | 435.34 Thousand USD | 0.0% |
2010 Q3 | 343.39 Thousand USD | 0.0% |
2010 Q4 | 435.34 Thousand USD | 26.78% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q1 | 2147.00 USD | -30.04% |
2006 Q2 | 2146.00 USD | -0.05% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | -100.0% |
2006 FY | - USD | -100.0% |
2005 Q3 | 3170.00 USD | -24.42% |
2005 Q2 | 4194.00 USD | -19.61% |
2005 Q4 | 3069.00 USD | -3.19% |
2005 FY | 3069.00 USD | -50.82% |
2005 Q1 | 5217.00 USD | -16.39% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | 6240.00 USD | 0.0% |
2004 Q4 | 6240.00 USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 Q4 | - USD | -100.0% |
2000 Q1 | - USD | 0.0% |
2000 Q3 | 1662.00 USD | -45.51% |
2000 FY | - USD | -100.0% |
2000 Q2 | 3050.00 USD | 0.0% |
1999 FY | 3050.00 USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 87.89% |
AngioDynamics, Inc. | 3.93 Million USD | -131.356% |
AtriCure, Inc. | 60.59 Million USD | 84.96% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 84.921% |
BioLife Solutions, Inc. | 18.31 Million USD | 50.231% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.639% |
Daxor Corporation | 755.65 Thousand USD | -1105.984% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | -88.599% |
Femasys Inc. | 4.25 Million USD | -114.015% |
GlucoTrack, Inc. | 196 Thousand USD | -4549.553% |
Harvard Bioscience, Inc. | 30.7 Million USD | 70.319% |
Hologic, Inc. | 2.49 Billion USD | 99.635% |
ICU Medical, Inc. | 1.57 Billion USD | 99.422% |
Intuitive Surgical, Inc. | -82.1 Million USD | 111.1% |
KORU Medical Systems, Inc. | 3.65 Million USD | -149.475% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 45.181% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 98.955% |
Microbot Medical Inc. | 40 Thousand USD | -22682.808% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -198356.511% |
Merit Medical Systems, Inc. | 823.01 Million USD | 98.893% |
Nephros, Inc. | 1.39 Million USD | -555.62% |
NovoCure Limited | 596.24 Million USD | 98.472% |
NEXGEL, Inc. | 513 Thousand USD | -1676.437% |
NEXGEL, Inc. | 513 Thousand USD | -1676.437% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 86.504% |
OraSure Technologies, Inc. | 11.38 Million USD | 19.976% |
Pro-Dex, Inc. | 7.53 Million USD | -20.928% |
Pulse Biosciences, Inc. | 8.08 Million USD | -12.702% |
Predictive Oncology Inc. | 2.18 Million USD | -316.318% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -370.241% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.599% |
Repligen Corporation | 510.14 Million USD | 98.214% |
STAAR Surgical Company | 31.46 Million USD | 71.039% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -2989.194% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.493% |
Jin Medical International Ltd. | - USD | -Infinity% |